Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.
Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332
Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2023), Lancet, 402, 1991 - 2003
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882
Ki67 and breast cancer mortality in women with invasive breast cancer.
Probert J. et al, (2023), JNCI Cancer Spectr, 7
Risk of breast cancer death after a diagnosis of early invasive breast cancer.
MacKenzie M. et al, (2023), BMJ, 381
Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?
Kirby AM. et al, (2023), BMJ, 381
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292
Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting
Kirby AM. et al, (2023), Clinical Oncology
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970-2009.
Duane FK. et al, (2022), Clin Transl Radiat Oncol, 36, 132 - 139
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Kerr AJ. et al, (2022), Cancer Treat Rev, 105
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophageal doses published 2013–2018
Duane F. et al, (2020), European Journal of Cancer, 138, S83 - S84
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Henson KE. et al, (2020), Int J Cancer, 147, 1437 - 1449
Eligibility for Partial Breast Radiotherapy in England.
Taylor CW. et al, (2020), Clin Oncol (R Coll Radiol), 32, 217 - 220
Heart failure after treatment for breast cancer.
Boekel NB. et al, (2020), Eur J Heart Fail, 22, 366 - 374
Heart failure after treatment for breast cancer
Taylor C. and DARBY S., (2019), European Journal of Heart Failure